Patent ID: 9505838
Filing Date: 2016-11-29
CPC Classification: A61K,A61P,C07K

Claim Text:
1. A method of treating migraines comprising administering to a human patient in need thereof a human engineered calcitonin gene related peptide (CGRP) antibody comprising a light chain variable region (LCVR) and a heavy chain variable region (HCVR), wherein the amino acid sequence of said LCVR and HCVR is selected from the group consisting of: a. LCVR of SEQ ID NO: 17 and HCVR of SEQ ID NO: 22; b. LCVR of SEQ ID NO: 18 and HCVR of SEQ ID NO: 23; c. LCVR of SEQ ID NO: 19 and HCVR of SEQ ID NO: 24; d. LCVR of SEQ ID NO: 20 and HCVR of SEQ ID NO: 25; and e. LCVR of SEQ ID NO: 21 and HCVR of SEQ ID NO: 26.